Hikma Pharmaceuticals USA v Amarin Pharma presents a complex dispute between Amarin, the manufacturer of Vascepa, a ...

A newly unsealed whistleblower suit claims that multiple CVS Health subsidiaries coordinated to prevent members from accessing generic drugs in a bid to boost the bottom line. The suit, first obtained ...

DifGen Pharmaceuticals shared that its partner, Apotex recently received approval from the Food and Drug Administration for nintedanib soft gel capsules, 100 mg and 150 mg, which is the generic of ...

I have been a clinical researcher for almost 50 years. After medical school and internal medicine residency, I was selected to go to the National Institutes of Health where I learned the basics of ...

The Association for Accessible Medicines’ annual U.S. Generic & Biosimilar Medicines Savings Report, in partnership with the IQVIA Institute, reveals that the use of Food and Drug Administration ...

Replacing high-cost generics with cheaper medications that have the same clinical benefit could have cut down spending and saved patients about 88%, according to Johns Hopkins research published in ...

The industry is entering “the golden era for biosimilars,” Amneal co-CEO Chirag Patel said Wednesday morning as he explained ...

Manufacturers of generic and biosimilar medicines should rethink their real world launch, lifecycle and litigation strategies ...

Affordable generic versions of Ozempic and Wegovy have quickly secured 20% of the Rs 1,600 crore weight-loss market following patent expiry. Early movers like Torrent and Sun Pharma are challenging ...

The human cost of the COVID-19 pandemic has been a strain on countries' ability to obtain medicines produced abroad with lockdowns shutting down inspections and snagging imports. Mexico, seeking an ...

Following the successful spin-off of its Sandoz generics division in late 2023, Novartis AG (NYSE:NVS) has transformed into a ...